Leukaemia Trial, Recruiting NCT07051525 Sponsor: Peter MacCallum Cancer Centre, Australia Condition: Leukaemia
Back to Leukaemia

Leukaemia Trial, Recruiting

NCT07051525
Recruiting Not Applicable 🇦🇺 Australian site

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You are receiving strong chemotherapy to prepare for a stem cell transplant (using your own or a donor's cells) or a CAR T cell therapy, OR you are receiving chemotherapy to treat acute leukaemia
  • You developed a fever (temperature of 38°C or higher) at some point during or after your chemotherapy, before your blood counts began to recover
  • Your fever has gone away (temperature stayed below 38°C) for at least 48 hours but less than 96 hours before joining the trial

Who may not be able to join:

  • Your fever lasted for 5 or more days in a row before it came down
  • A blood test found bacteria in your blood (a positive blood culture) during this fever episode, before you could be enrolled
  • You have another confirmed or suspected infection that needs antibiotic treatment
  • You have a moderate or severe mouth sore condition, or a serious bowel inflammation linked to low blood counts (confirm with trial site)
  • You are medically unstable or have been admitted to an intensive care unit (ICU) at the time of potential enrolment
  • You took part in another randomised trial within the last 28 days
  • You have already been enrolled in this trial during the same chemotherapy cycle
  • You are pregnant or breastfeeding
  • You are currently being treated for a severe immune reaction related to CAR T cell therapy (specifically grade 3 or 4 CRS or ICANS) (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Peter MacCallum Cancer Centre, Australia
Registry
ClinicalTrials.gov
Start date
3 December 2025
Est. completion
5 December 2027

Where this trial is recruiting

🇦🇺 Australia

2 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Days free of antibiotic therapy in 28 days post randomization (termed empiric antibiotic free days (EAFDs))

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov